AAAAAA
Results: 76-100/220
Authors:
TREPO C
BAILLY F
BIZOLLON T
Citation: C. Trepo et al., TREATMENT OF CHRONIC HEPATITIS-C - ANOTHER THERAPEUTIC OPTION, Nephrology, dialysis, transplantation, 11, 1996, pp. 62-64
Authors:
VIAL T
BAILLY F
DESCOTES J
TREPO C
Citation: T. Vial et al., SIDE-EFFECTS OF ALPHA-INTERFERON, Gastroenterologie clinique et biologique, 20(5), 1996, pp. 462-489
Authors:
VERGNON P
COLIN C
JULLIEN AM
BORY E
EXCOFFIER S
MATILLON Y
TREPO C
AYMARD JP
BASTIT D
BIDET ML
BREVIERE R
CHENAIS F
HOUSSAY D
MERCADIER A
MAISONNEUVE P",LAMBERT,"WALLER C
BOUDART D
COTTE C
ELGHOUZZI MH
JANOT C
DAUDET M
MENAULT M",MONTCHARMONT,"SMILOVICI W
FRETZ C
FOLLANA R
DOILLON M
LEPETIT JC
HERVE P
LOYER B
MATTLINGER B
Citation: P. Vergnon et al., ECONOMIC AND MEDICAL EVALUATION OF THE SC REENING OF C-HEPATITIS AND NON-A-NON-B-NON-C-HEPATITIS ON DONATED BLOOD, Revue d'epidemiologie et de sante publique, 44(1), 1996, pp. 66-79
Authors:
TREPO C
JEZEK P
ATKINSON GF
BOOM RJ
Citation: C. Trepo et al., EFFICACY OF FAMCICLOVIR IN CHRONIC HEPATITIS-B - RESULTS OF A DOSE-FINDING STUDY, Hepatology, 24(4), 1996, pp. 247-247
Authors:
AGUESSE S
BOREL C
CHEVALIER M
LIU SH
CHU CK
CHENG YC
TREPO C
ZOULIM F
Citation: S. Aguesse et al., INHIBITORY EFFECT OF 2'-FLUORO-5-METHYL-B-L-ARABINOSYLURACIL (L-FMAU), A NOVEL L-NUCLEOSIDE ANALOG, ON DUCK HEPATITIS-B VIRUS-REPLICATION, Hepatology, 24(4), 1996, pp. 372-372
HCV RECURRENCE AFTER OLT - A PILOT-STUDY OF RIBAVIRIN THERAPY FOLLOWING INITIAL COMBINATION WITH IFN
Authors:
BIZOLLON T
PALAZZO U
CHEVALLIER M
DUCERF C
TREPO C
Citation: T. Bizollon et al., HCV RECURRENCE AFTER OLT - A PILOT-STUDY OF RIBAVIRIN THERAPY FOLLOWING INITIAL COMBINATION WITH IFN, Hepatology, 24(4), 1996, pp. 667-667
Authors:
HABERSETZER F
FOURNILLIER A
DUBUISSON J
WYCHOWSKI C
NAKANO I
DESGRANGES C
INCHAUSPE G
TREPO C
Citation: F. Habersetzer et al., ISOLATION OF HUMAN MONOCLONAL-ANTIBODIES (HMABS) DIRECTED AT CONFORMATIONAL DETERMINANTS OF THE HEPATITIS-C VIRUS (HCV) E2 ENVELOPE PROTEIN, Hepatology, 24(4), 1996, pp. 1020-1020
Authors:
BONNAND AM
POUPON R
QUENEAU PE
TREPO C
COHARD M
VETTER D
RAABE JJ
LAMEY D
GRANGE JD
CAPRON JP
SERFATY L
CHRETIEN Y
SAINTMARCGIRARDIN MF
MATHIEXFORTUNET H
ZAFRANI ES
POUPON RE
Citation: Am. Bonnand et al., INTERFERON-ALFA AND URSODEOXYCHOLIC ACID COMBINATION VERSUS INTERFERON ALONE IN THE TREATMENT OF CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED TRIAL, Hepatology, 24(4), 1996, pp. 1107-1107
Authors:
WANG Z
STUYVER L
PICHOUD C
HABERSETZER F
TREPO C
ZOULIM F
Citation: Z. Wang et al., HEPATITIS-B VIRUS GENOME VARIABILITY IN CHRONIC HEPATITIS-B AND ITS INFLUENCE ON THE OUTCOME OF ANTIVIRAL THERAPY OF HBE AG (-) CHRONIC HEPATITIS-B, Hepatology, 24(4), 1996, pp. 1121-1121
Authors:
HABERSETZER F
ZOULIM F
JUSOT JF
ZHANG XX
COHARD M
TRABAUD MA
CHOSSEGROS P
ZARSKY JP
CHEVALLIER P
CHEVALLIER M
AHMED NS
SEPETJAN M
TREPO C
Citation: F. Habersetzer et al., EVALUATION OF BRANCHED DNA ASSAY (BDNA) FOR THE DETECTION OF HBV DNA IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS-B LACKING HBE ANTIGEN, Hepatology, 24(4), 1996, pp. 1570-1570
Authors:
PARANA R
COTRIM H
FATMI A
BERTHILLON P
ANDRADE Z
VITVITSKI L
TREPO C
LYRA L
Citation: R. Parana et al., NATURAL-HISTORY OF ACUTE SPORADIC (AS) NON-A,B,C,E HEPATITIS IN BAHIA, BRAZIL, Hepatology, 24(4), 1996, pp. 1732-1732
Authors:
KROGSGAARD K
CHRISTENSEN E
BINDSLEV N
SCHALM S
ANDERSEN PK
RINGLARSEN H
CARRENO V
CRAXI A
GERKEN G
SCHLICHTING P
THOMAS HC
TREPO C
Citation: K. Krogsgaard et al., RELATION BETWEEN TREATMENT EFFICACY AND CUMULATIVE DOSE OF ALPHA-INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 795-802
Authors:
KROGSGAARD K
MARCELLIN P
TREPO C
BERTHELOT P
SANCHEZTAPIAS JM
BASSENDINE M
TRAN A
OUZAN D
RINGLARSEN H
LINDBERG J
ENRIQUEZ J
BENHAMOU JP
BINDSLEV N
BERTET S
BOYER N
BRIND A
CIVEIRA MP
HOUSSET C
LUNDLAURSEN A
MAS A
POL S
PRIETO J
QUEDENS J
RAMPAL P
SCHLICHTING P
SORIANO G
SPACEY BEM
HAWLEY S
BRAND C
HOWE I
Citation: K. Krogsgaard et al., PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 803-813
Authors:
BERTHILLON P
CRANCE JM
LEVEQUE F
JOUAN A
PETIT MA
DELOINCE R
TREPO C
Citation: P. Berthillon et al., INHIBITION OF THE EXPRESSION OF HEPATITIS-A AND HEPATITIS-B VIRUSES (HAV AND HBV) PROTEINS BY INTERFERON IN A HUMAN HEPATOCARCINOMA CELL-LINE (PLC PRF/5)/, Journal of hepatology, 25(1), 1996, pp. 15-19
Authors:
ZOULIM F
ZHANG XX
PICHOUD C
TREPO C
Citation: F. Zoulim et al., HETEROGENEITY OF HEPATITIS-B VIRUS (HBV) CORE GENE IN A PATIENT WITH HBV-ASSOCIATED CIRRHOSIS AND SERUM NEGATIVITY FOR ANTI-HBC, Journal of hepatology, 24(2), 1996, pp. 155-160
Authors:
GERKEN G
PONTISSO P
ROGGENDORF M
RUMI MG
SIMMONDS P
TREPO C
ZEUZEM S
COLUCCI G
Citation: G. Gerken et al., CLINICAL-EVALUATION OF A SINGLE REACTION, DIAGNOSTIC POLYMERASE CHAIN-REACTION ASSAY FOR THE DETECTION OF HEPATITIS-C VIRUS-RNA, Journal of hepatology, 24(1), 1996, pp. 33-37
Authors:
TREPO C
ESTEBAN R
Citation: C. Trepo et R. Esteban, UNTITLED - FOREWORD, Digestive diseases and sciences, 41(12), 1996, pp. 1-2
Authors:
TREPO C
BAILLY F
Citation: C. Trepo et F. Bailly, MAGNITUDE AND MANAGEMENT OF HCV INFECTION IN FRANCE, Digestive diseases and sciences, 41(12), 1996, pp. 22-26
Authors:
ZHANG XX
ZOULIM F
HABERSETZER F
XIONG SD
TREPO C
Citation: Xx. Zhang et al., ANALYSIS OF HEPATITIS-B VIRUS GENOTYPES AND PRECORE REGION VARIABILITY DURING INTERFERON TREATMENT OF HBE ANTIGEN NEGATIVE CHRONIC HEPATITIS-B, Journal of medical virology, 48(1), 1996, pp. 8-16
Authors:
ZOULIM F
DANNAOUI E
BOREL C
HANTZ O
LIN TS
LIU SH
TREPO C
CHENG YC
Citation: F. Zoulim et al., 2',3'-DIDEOXY-BETA-L-5-FLUOROCYTIDINE INHIBITS DUCK HEPATITIS-B VIRUSREVERSE TRANSCRIPTION AND SUPPRESSES VIRAL-DNA SYNTHESIS IN HEPATOCYTES, BOTH IN-VITRO AND IN-VIVO, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 448-453
Authors:
VIDALIN O
MAJOR ME
RAYNER B
IMBACH JL
TREPO C
INCHAUSPE G
Citation: O. Vidalin et al., IN-VITRO INHIBITION OF HEPATITIS-C VIRUS GENE-EXPRESSION BY CHEMICALLY-MODIFIED ANTISENSE OLIGODEOXYNUCLEOTIDES, Antimicrobial agents and chemotherapy, 40(10), 1996, pp. 2337-2344
Authors:
BIZOLLON T
ADAHM M
DUCERF C
BAULIEUX J
TREPO C
Citation: T. Bizollon et al., NEW APPROACHES TO TREATMENT OF RECURRENT HEPATITIS-C VIRUS FOLLOWING LIVER-TRANSPLANTATION USING RIBAVIRIN, Transplantation proceedings, 28(5), 1996, pp. 2842-2843
Authors:
TURIN F
BOREL C
BENCHAIB M
KAY T
JAMARD C
GUGUENGUILLOUZO C
TREPO C
HANTZ O
Citation: F. Turin et al., N-BUTYRATE, A CELL-CYCLE BLOCKER, INHIBITS EARLY AMPLIFICATION OF DUCK HEPATITIS-B VIRUS COVALENTLY CLOSED CIRCULAR DNA AFTER IN-VITRO INFECTION OF DUCK HEPATOCYTES, Journal of virology, 70(5), 1996, pp. 2691-2696
Authors:
LEPORT C
CHENE G
MORLAT P
LUFT BJ
ROUSSEAU F
PUEYO S
HAFNER R
MIRO J
AUBERTIN J
SALAMON R
VILDE JL
BLANC AP
SCHMITT JL
ARLAUD J
ESTAVOYER JM
GUILLEVIN L
BENTATA M
BEYLOT J
LACUT JY
GRANIER P
COSNARD F
BAZIN C
DORMONT J
REY M
DELAUNAY C
TROISVALLET D
MICOUD M
WEINBRECK P
TREPO C
GALLAIS H
GASTAUT JA
ALLARD C
JANBON F
CANTON P
GROLLEAU JY
CASSUTO J
DELLAMONICA P
DURET P
FROTTIER J
HERSON S
SELIGMANN M
SERENI D
GIRAUDON BB
DIEN G
RUEL M
STORCK D
JAUBERT D
LAFEUILLADE A
MOUTON Y
CHOUTET P
LAFAIX C
GATELL JM
GUELAR A
MILDVAN D
SOIERO R
JACOBSON JM
MURRAY HW
STEIGBIGEL NH
SACHS HH
VALENTINE F
GRIECO MH
ARMSTRONG D
LEDERMAN M
BARTLETT JA
WASKIN HA
NICHOLAS P
FESSEL JW
MACARTHUR RD
GLATT AE
PHAIR JP
POWDERLY W
HEWITT R
STEIGBIGEL RT
BLAIR DC
SKAHAN KJ
FRAME P
CHEESEMAN SH
CONNOR EM
BALFOUR HH
VANDERHORST C
HO M
Citation: C. Leport et al., PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL, The Journal of infectious diseases, 173(1), 1996, pp. 91-97
Authors:
LERAT H
BERBY F
TRABAUD MA
VIDALIN O
MAJOR M
TREPO C
INCHAUSPE G
Citation: H. Lerat et al., SPECIFIC DETECTION OF HEPATITIS-C VIRUS MINUS-STRAND RNA IN HEMATOPOIETIC-CELLS, The Journal of clinical investigation, 97(3), 1996, pp. 845-851